United Network for Organ Sharing (UNOS) updated the heart transplant allocation system in 2018 in an effort to improve waitlist times and better prioritize the sickest candidates. The new allocation system added new statuses 1 through 3 at the top of the waitlist in place of former status 1A, with temporary mechanical support (MCS) including extracorporeal membrane oxygenation (ECMO), intra-aortic balloon pump (IABP), and other temporary ventricular and biventricular support associated with the highest two statuses. 1 Other common listing strategies such as high-dose inpatient inotrope use and durable ventricular assist devices (LVAD) became statuses 3 and 4, respectively. Early experiences with the impact of the new allocation system identified an increase in temporary MCS (predominantly IABP) and variable effects on post-transplant survival. [2][3][4][5][6] However, there are limited data about the effects of the new allocation system on waitlist outcomes, 3,6 and specifically, the effects on waitlist outcomes stratified by various transplant listing strategies. Ongoing updates to the UNOS dataset allow for additional follow-up time and analyses of waitlist outcomes based on listing strategy. These